InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Akamine Scott. Director active across 1 company, notably Cerevel Therapeutics Holdings, Inc.. Aggregated, 5 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €392k. Activity tracked since 8 August 2022. The latest transaction was disclosed on 5 December 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Akamine Scott is a declarant linked to Cerevel Therapeutics Holdings, Inc., where he is Chief Legal Officer. Across 5 filings, all 5 are in the recent sample, covering the period from 2022-08-09 to 2024-08-05, with EUR 0 in buys and EUR 392249 in sells; the modal transaction nature is option exercise.